Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Immunogenicity of a combined schedule of 7-valent pneumococcal conjugate vaccine followed by a 23-valent polysaccharide vaccine in adult recipients of heart or lung transplants.

Gattringer R, Winkler H, Roedler S, Jaksch P, Herkner H, Burgmann H.

Transpl Infect Dis. 2011 Oct;13(5):540-4. doi: 10.1111/j.1399-3062.2011.00628.x. Epub 2011 Apr 13.

PMID:
21489090
2.

Determining the optimal pneumococcal vaccination strategy for adults: is there a role for the pneumococcal conjugate vaccine?

Metersky ML, Dransfield MT, Jackson LA.

Chest. 2010 Sep;138(3):486-90. doi: 10.1378/chest.10-0738. Epub 2010 Jun 24.

PMID:
20576729
3.

Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults.

Musher DM, Manof SB, Liss C, McFetridge RD, Marchese RD, Bushnell B, Alvarez F, Painter C, Blum MD, Silber JL.

J Infect Dis. 2010 Feb 15;201(4):516-24. doi: 10.1086/649839.

PMID:
20092407
4.

Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 > or = years.

Manoff SB, Liss C, Caulfield MJ, Marchese RD, Silber J, Boslego J, Romero-Steiner S, Rajam G, Glass NE, Whitney CG, Carlone GM.

J Infect Dis. 2010 Feb 15;201(4):525-33. doi: 10.1086/651131.

PMID:
20088694
5.

Guidelines for vaccination of solid organ transplant candidates and recipients.

Danzinger-Isakov L, Kumar D; AST Infectious Diseases Community of Practice..

Am J Transplant. 2009 Dec;9 Suppl 4:S258-62. doi: 10.1111/j.1600-6143.2009.02917.x. No abstract available.

6.

The immunogenicity of 7-valent pneumococcal conjugate vaccine versus 23-valent polysaccharide vaccine in adults aged 50-80 years.

Goldblatt D, Southern J, Andrews N, Ashton L, Burbidge P, Woodgate S, Pebody R, Miller E.

Clin Infect Dis. 2009 Nov 1;49(9):1318-25. doi: 10.1086/606046.

PMID:
19814624
7.

Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease.

Dransfield MT, Nahm MH, Han MK, Harnden S, Criner GJ, Martinez FJ, Scanlon PD, Woodruff PG, Washko GR, Connett JE, Anthonisen NR, Bailey WC; COPD Clinical Research Network..

Am J Respir Crit Care Med. 2009 Sep 15;180(6):499-505. doi: 10.1164/rccm.200903-0488OC. Epub 2009 Jun 25.

8.

A randomized, double-blind, placebo-controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in adult liver transplant recipients.

Kumar D, Chen MH, Wong G, Cobos I, Welsh B, Siegal D, Humar A.

Clin Infect Dis. 2008 Oct 1;47(7):885-92. doi: 10.1086/591537.

PMID:
18715160
9.

Risks of invasive pneumococcal disease in children with underlying chronic diseases.

Hjuler T, Wohlfahrt J, Staum Kaltoft M, Koch A, Biggar RJ, Melbye M.

Pediatrics. 2008 Jul;122(1):e26-32. doi: 10.1542/peds.2007-1510.

PMID:
18595971
10.

Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory.

de Roux A, Schmöle-Thoma B, Siber GR, Hackell JG, Kuhnke A, Ahlers N, Baker SA, Razmpour A, Emini EA, Fernsten PD, Gruber WC, Lockhart S, Burkhardt O, Welte T, Lode HM.

Clin Infect Dis. 2008 Apr 1;46(7):1015-23. doi: 10.1086/529142. Erratum in: Clin Infect Dis. 2008 May 1;46(9):1488. Schmöele-Thoma, B [corrected to Schmöle-Thoma, B].

PMID:
18444818
11.

Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults.

Lesprit P, Pédrono G, Molina JM, Goujard C, Girard PM, Sarrazin N, Katlama C, Yéni P, Morineau P, Delfraissy JF, Chêne G, Lévy Y; ANRS 114-Pneumovac Study Group..

AIDS. 2007 Nov 30;21(18):2425-34.

PMID:
18025879
12.

Predictors of pneumococcal conjugate vaccine immunogenicity among infants and toddlers in an American Indian PnCRM7 efficacy trial.

O'Brien KL, Moisi J, Moulton LH, Madore D, Eick A, Reid R, Weatherholtz R, Millar E, Hu D, Hackell J, Kohberger R, Siber G, Santosham M.

J Infect Dis. 2007 Jul 1;196(1):104-14. Epub 2007 May 24.

PMID:
17538890
13.

Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide-protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.

Jackson LA, Neuzil KM, Nahm MH, Whitney CG, Yu O, Nelson JC, Starkovich PT, Dunstan M, Carste B, Shay DK, Baggs J, Carlone GM.

Vaccine. 2007 May 16;25(20):4029-37. Epub 2007 Mar 12.

PMID:
17391816
14.

Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies.

Siber GR, Chang I, Baker S, Fernsten P, O'Brien KL, Santosham M, Klugman KP, Madhi SA, Paradiso P, Kohberger R.

Vaccine. 2007 May 10;25(19):3816-26. Epub 2007 Feb 21.

PMID:
17368878
15.

Invasive pneumococcal disease in solid organ transplant recipients--10-year prospective population surveillance.

Kumar D, Humar A, Plevneshi A, Green K, Prasad GV, Siegal D; Toronto Invasive Bacterial Diseases Network., McGeer A.

Am J Transplant. 2007 May;7(5):1209-14. Epub 2007 Feb 7.

16.

Immunogenicity of pneumococcal vaccine in renal transplant recipients--three year follow-up of a randomized trial.

Kumar D, Welsh B, Siegal D, Chen MH, Humar A.

Am J Transplant. 2007 Mar;7(3):633-8. Epub 2007 Jan 11.

17.

Impaired anti-pneumococcal polysaccharide antibody production and invasive pneumococcal infection following heart transplantation.

Sarmiento E, Rodríguez-Hernández C, Rodríguez-Molina J, Fernández-Yánez J, Palomo J, Anguita J, Pérez JL, Lanio N, Fernández-Cruz E, Carbone J.

Int Immunopharmacol. 2006 Dec 20;6(13-14):2027-30. Epub 2006 Oct 17.

PMID:
17161358
18.

Immunogenicity of sequential pneumococcal vaccination in subjects splenectomised for hereditary spherocytosis.

Stoehr GA, Rose MA, Eber SW, Heidemann K, Schubert R, Zielen S.

Br J Haematol. 2006 Mar;132(6):788-90.

PMID:
16487181
19.

Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study.

Goldblatt D, Hussain M, Andrews N, Ashton L, Virta C, Melegaro A, Pebody R, George R, Soininen A, Edmunds J, Gay N, Kayhty H, Miller E.

J Infect Dis. 2005 Aug 1;192(3):387-93. Epub 2005 Jun 23.

PMID:
15995951
20.

A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma.

Landgren O, Björkholm M, Konradsen HB, Söderqvist M, Nilsson B, Gustavsson A, Axdorph U, Kalin M, Grimfors G.

J Intern Med. 2004 Jun;255(6):664-73.

Supplemental Content

Support Center